Core Insights - Nanox Imaging Ltd has announced a clinical and educational collaboration with Keiser University to deploy its advanced imaging system, Nanox.ARC, for training healthcare professionals [1][2] Company Overview - Nanox is focused on transforming healthcare through affordable medical imaging technologies, utilizing advanced AI and proprietary digital X-ray sources [6][7] - The company aims to enhance early detection and treatment of diseases, improving health outcomes globally [7] Product Details - The Nanox.ARC is a 3D digital tomosynthesis imaging system that offers improved sensitivity and specificity compared to traditional X-ray, while also reducing patient radiation exposure and radiologist reading times compared to CT scans [3][9] - The system features a proprietary digital X-ray source powered by cold cathode technology, providing a detailed, layered view of the body [3][9] Collaboration with Keiser University - The Nanox.ARC will be integrated into Keiser University's Radiologic Technology graduate program, allowing students and local medical imaging providers to access the technology for educational purposes [2][5] - This partnership is expected to enhance clinical education and empower future healthcare professionals with innovative diagnostic tools [5] Keiser University Overview - Keiser University is Florida's largest private, non-profit university, serving nearly 20,000 students across 21 campuses and online [4][10] - The university has awarded approximately 100,000 degrees since its establishment in 1977 and is recognized for its contributions to workforce talent in healthcare and nursing [4][10]

Core Viewpoint - Nanox Imaging Ltd has received EU MDR CE mark certification for its HealthOST software, enabling commercialization in Europe and ensuring compliance with regulatory standards for medical software [1][2]. Company Overview - Nanox is an innovative medical imaging technology company focused on preventive healthcare through affordable imaging technologies based on advanced AI [10][11]. - The company aims to enhance early detection and treatment of diseases, improving health outcomes globally [11]. Product Details - HealthOST is an advanced software solution that analyzes routine CT scans to assess vertebral height loss and bone mineral density, aiding in the evaluation of musculoskeletal diseases like osteoporosis [2][8]. - The software integrates with existing picture archiving and communication systems (PACS) and requires no additional imaging or patient time, making it a cost-effective screening tool [3][5]. Market Need - Osteoporosis affects over 25.5 million women in Europe, with a significant portion of vertebral compression fractures going undetected [4]. - The annual cost of osteoporosis-related fractures in Europe exceeds €56 billion, with cases expected to increase by 25% by 2034 due to an aging population [4]. Clinical Impact - In the ADOPT study, HealthVCF identified over 3,450 new patients with vertebral compression fractures, highlighting the software's effectiveness in detecting previously undiagnosed cases [6][7]. - The integration of Nanox.AI's solutions has shown to improve patient outcomes and reduce the burden on healthcare systems through preventive care [7].

Key Takeaways Boston Scientific saw 9.8% operational sales growth in emerging markets in Q1 2025 despite geopolitical risks. BSX benefits from favorable economic trends, healthcare infrastructure and sustained investment. BSX competes with ABT and MDT, which also report strong emerging market growth and localization efforts.Emerging markets remain a vital growth engine for Boston Scientific Corporation (BSX) , anchoring the company’s broader international strategy and long-term expansion plans. In the fir ...

Industry Overview - Health and fitness companies focus on improving physical well-being through products and services such as gym memberships, fitness equipment, nutritional supplements, and wellness programs [1] - The industry benefits from consistent demand driven by growing global awareness of health issues and the importance of physical fitness, supported by rising rates of lifestyle-related diseases and a growing emphasis on preventive healthcare [3] - Diverse revenue streams, including subscriptions, product sales, and services, make the health and fitness sector attractive to investors seeking long-term gains [4] Investment Opportunities - Five recommended stocks in the health and fitness space with favorable Zacks Rank include Sprouts Farmers Market Inc. (SFM), DexCom Inc. (DXCM), Hims & Hers Health Inc. (HIMS), United Natural Foods Inc. (UNFI), and GoodRx Holdings Inc. (GDRX) [2] Company Highlights Sprouts Farmers Market Inc. (SFM) - Focus on product innovation, e-commerce, private label offerings, and targeted marketing has led to better-than-expected fourth-quarter 2024 results, with both top and bottom lines growing year over year [6] - Expected net sales growth of 10.5% to 12.5% and comparable store sales increase of 4.5% to 6.5% for 2025 [7] - Projected revenue and earnings growth rates of 13.7% and 33.6%, respectively, for the current year [8] DexCom Inc. (DXCM) - Benefiting from strong contributions from the Sensor segment and both domestic and international revenue growth [10] - Expected revenue and earnings growth rates of 14.3% and 23.2%, respectively, for the current year [11] Hims & Hers Health Inc. (HIMS) - Addresses a $360 million U.S. total addressable market across various healthcare specialties, with over 2 million subscribers driving recurring revenues [12] - Expected revenue and earnings growth rates of 58.5% and more than 100%, respectively, for the current year [13] United Natural Foods Inc. (UNFI) - Demonstrating strong growth supported by wholesale momentum and demand for natural and organic products [14] - Expected revenue and earnings growth rates of 1.9% and more than 100%, respectively, for the current year [16] GoodRx Holdings Inc. (GDRX) - Offers a price comparison platform for prescription drugs, enabling consumers to save on purchases [17] - Expected revenue and earnings growth rates of 4% and 14.7%, respectively, for the current year [19]

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicationsEnhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play' installation processSystem design enables software upgrades and new capabilities to be added remotely following future regulatory clearances PETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , N ...